Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > Press > Nobel laureate Roger Tsien, PhD, keynotes Cedars-Sinai nanomedicine conference March 15, 16

Abstract:
Nobel laureate Roger Tsien, PhD, will keynote Cedars-Sinai's March 15 and 16 Nanomedicine for Imaging and Treatment Conference, which will assemble a multidisciplinary group of nationally and internationally renowned academic researchers, clinicians and representatives from private industry and the National Institutes of Health.

Nobel laureate Roger Tsien, PhD, keynotes Cedars-Sinai nanomedicine conference March 15, 16

Los Angeles, CA | Posted on March 8th, 2013

Tsien, professor of pharmacology, chemistry and biochemistry at the University of California, San Diego, shared the 2008 Nobel Prize in chemistry for the discovery and development of the green fluorescent protein (GFP), which glows bright green and is found in one species of jellyfish. Among its biochemical uses, synthetic green fluorescent protein can be bound to other proteins to track their movement and behavior.

Experts from two dozen organizations will lead sessions on identified and emerging issues in nanomedicine, focusing on recent achievements in drug delivery, nanomedicine and imaging, the role of the NIH in nanodrug development, and the latest preclinical and clinical advances in the treatment of cancer, neurodegenerative diseases and other conditions. The program was designed to provide many opportunities for those attending to talk and share ideas with members of the faculty.

Scientists specializing in nanotechnology and nanomedicine generally work with substances smaller than 100 nanometers. One nanometer is one-millionth of a millimeter. A sheet of paper is 100,000 nanometers thick and a strand of human DNA is 2.5 nanometers in diameter. Nano researchers manipulate substances and materials in the realm of their atomic makeup.

"Nanotechnology has the real potential to revolutionize a wide array of medical and biotechnology tools and procedures so that they are more personalized, portable, cheaper, safer and easier to administer," according to the United States National Nanotechnology Initiative website, which says nanomedicine already is making an impact in many areas, such as biological imaging for early disease diagnosis, molecular imaging for early cancer detection, therapeutic targeting of cancer cells, and monitoring of individual cells and molecules as they move in their environments.

The conference's March 15 sessions will focus on nanomedicine for advanced imaging and targeted drug delivery. Tsien's 1 p.m. presentation will be on new molecules to image neuronal function and disease processes. Other sessions will include:

- Transport oncophysics and opportunities for nanomedicine
- Bringing nanomedicines to cell organelles
- Nanoscale electrostatic delivery systems: from layered nanoparticles to RNAi microsponges
- Design and biorecognition of water-soluble macromolecular therapeutics
- Multivalent hyperbranched polymeric nanoparticles as self-reporting drug delivery vehicles
- A window into the Alzheimer's brain
- Direct brain MR-guided delivery of nanoparticles in neuro-oncology and neurodegenerative disorders
- MRI of cancer using targeted contrast agents
- Mapping the human vasculature by in vivo phage display
- Ligand-directed targeting and molecular imaging in translational medicine
- A discussion on multidisciplinary research in oncology, with a panel of experts from the National Institutes of Health

March 16 sessions, spotlighting nanotechnology's major role in the future of medical treatment, will include:

- Nanotechnology for medicine
- Harnessing the combined powers of antibody-fusion proteins and nanopolymers for cancer therapy
- Nanomedicine for targeted drug delivery to epithelial barriers of intestines, skin and lung
- The clinical significance of iron oxide nanoparticles
- Supramolecular nanomedicines for targeted cancer therapy
- Nanotechnology strategies to overcome multidrug resistance
- Protein-based nanoparticles target tumors and drug resistance
- Nanobiomaterials: advances, safety and security
- Translating nanomedical research into nanomedical applications
- Panel discussion among industry and legal experts

This will be Cedars-Sinai's second nanomedicine conference for science and health care professionals, presented by the Department of Neurosurgery and the Samuel Oschin Comprehensive Cancer Institute.

It will be directed by Julia Y. Ljubimova, MD, PhD, professor of neurosurgery and biomedical sciences, and director of the Nanomedicine Research Center in the Department of Neurosurgery. Ljubimova and colleagues have published preclinical studies on a nanodrug transport system for targeted treatment of biological mechanisms in brain tumor and breast cancer cells.

Participating Cedars-Sinai faculty will include:

- Keith L. Black, MD, professor and chair of the Department of Neurosurgery, director of the Maxine Dunitz Neurosurgical Institute, co-director of the Johnnie L. Cochran, Jr. Brain Tumor Center, and the Ruth and Lawrence Harvey Chair in Neuroscience
- Robert Figlin, MD, professor of medicine and biomedical sciences, director of the Division of Hematology/Oncology in the Samuel Oschin Comprehensive Cancer Institute, and the Steven Spielberg Family Chair in Hematology/Oncology
- Eggehard Holler, PhD, professor and director of Drug Synthesis in the Department of Neurosurgery
- Shlomo Melmed, MD, professor of medicine, senior vice president for Academic Affairs, dean of the medical faculty, director of the Cedars-Sinai Research Institute, and the Helene A. and Philip E. Hixon Chair in Investigative Medicine
- Steven Piantadosi, MD, PhD, professor, director of the Samuel Oschin Comprehensive Cancer Institute, and the Phase One Foundation Chair

####

For more information, please click here

Contacts:
Sandy Van
Telephone: 808-526-1708 or 800-880-2397

Copyright © Cedars-Sinai Medical Center

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Keeping electric car design on the right road: A closer look at the life-cycle impacts of lithium-ion batteries and proton exchange membrane fuel cells December 9th, 2016

Further improvement of qubit lifetime for quantum computers: New technique removes quasiparticles from superconducting quantum circuits December 9th, 2016

Chemical trickery corrals 'hyperactive' metal-oxide cluster December 8th, 2016

Scientists track chemical and structural evolution of catalytic nanoparticles in 3-D: Up-close, real-time, chemical-sensitive 3-D imaging offers clues for reducing cost/improving performance of catalysts for fuel-cell-powered vehicles and other applications December 8th, 2016

Nanomedicine

Arrowhead Pharmaceuticals to Webcast Fiscal 2016 Year End Results December 7th, 2016

Fast, efficient sperm tails inspire nanobiotechnology December 5th, 2016

Journal Nanotechnology Progress International (JONPI) Volume 6, issue 2 coming out soon! December 5th, 2016

UTSA study describes new minimally invasive device to treat cancer and other illnesses: Medicine diffusion capsule could locally treat multiple ailments and diseases over several weeks December 3rd, 2016

Announcements

Keeping electric car design on the right road: A closer look at the life-cycle impacts of lithium-ion batteries and proton exchange membrane fuel cells December 9th, 2016

Further improvement of qubit lifetime for quantum computers: New technique removes quasiparticles from superconducting quantum circuits December 9th, 2016

Researchers peer into atom-sized tunnels in hunt for better battery: May improve lithium ion for larger devices, like cars December 8th, 2016

Scientists track chemical and structural evolution of catalytic nanoparticles in 3-D: Up-close, real-time, chemical-sensitive 3-D imaging offers clues for reducing cost/improving performance of catalysts for fuel-cell-powered vehicles and other applications December 8th, 2016

Events/Classes

Arrowhead Pharmaceuticals to Webcast Fiscal 2016 Year End Results December 7th, 2016

In IEDM 2016 Keynote, Leti CEO Says ‘Hyperconnectivity’, Human-focused Research and the IOT Promise Profound, Positive Changes December 7th, 2016

IEDM: Leti CEO Marie Semeria to Give Opening-day Keynote on Impact of ‘Hyperconnectivity’ and IoT: Speech to Portray Key Role Nonprofit Research and Technology Organizations Play in Making Technology More Efficient and Ensuring Safety and Security November 29th, 2016

Leti and Grenoble Partners Demonstrate World’s 1st Qubit Device Fabricated in CMOS Process: Paper by Leti, Inac and University of Grenoble Alpes Published in Nature Communications November 28th, 2016

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project